Classen Immunotherapies, Inc. v. Biogen IDEC

177 L. Ed. 2d 1119, 130 S. Ct. 3541, 561 U.S. 1040, 2010 U.S. LEXIS 5533, 79 U.S.L.W. 3006
Supreme Court of the United States·Decided June 29, 2010·No. No. 08-1509·Published·Cited by 2 cases

Opinion

Petition for writ of cer-tiorari granted. Judgment vacated, and [1120] case remanded to the United States Court of Appeals for the Federal Circuit for further consideration in light of Bilski v. Kappos, 561 U.S. 593, 130 S. Ct. 3218, 177 L. Ed. 2d 792 (2010).

Same case below, 304 Fed. Appx. 866.

Free access — add to your briefcase to read the full text and ask questions with AI

Classen Immunotherapies, Inc. v. Biogen IDEC, 177 L. Ed. 2d 1119, 130 S. Ct. 3541, 561 U.S. 1040, 2010 U.S. LEXIS 5533, 79 U.S.L.W. 3006 (U.S. 2010).

177 L. Ed. 2d 1119 (Classen Immunotherapies, Inc. v. Biogen IDEC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Classen Immunotherapies, Inc. v. Biogen Idec
659 F.3d 1057 (Federal Circuit, 2011)